CorMedix Inc (NASDAQ: CRMD) stock enjoyed a major increase of 14.0% on 3/13/24. The shares closed at $3.90. Moreover, this advance was accompanied by exceptionally high trading volume at 259% of normal. Relative to the market the stock has been weak over the last nine months but has risen 9.9% during the last week.
Current PriceTarget Research Rating
CRMD is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
CorMedix has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. CorMedix has a poor Power Rating of 24 and a very low Appreciation Score of 7, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment